FDA Inspection
AMAG Pharma USA, Inc.AMAG Pharma USA, Inc. – FDA Inspection, Feb 2, 2009
Record Details
This FDA Inspection record concerns AMAG Pharma USA, Inc., with an inspection on February 2, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AMAG Pharma USA, Inc.
- Inspection Date
- February 2, 2009
- Product Type
- Drugs
View Company Profile
ID · f0a7744f-1144-4359-8277-ebaa4c3d965a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 568770
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AMAG Pharma USA, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 20, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AMAG Pharma USA, Inc.
- FDA Inspection 709390 - 2011-02-11
- FDA Inspection 677263 - 2010-08-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.